Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

被引：0
作者：
Franco Maggiolo
Roberto Gulminetti
Layla Pagnucco
Margherita Digaetano
Adriana Cervo
Daniela Valenti
Annapaola Callegaro
Cristina Mussini
机构：
[1] ASST Papa Giovanni XXIII,Division of Infectious Diseases
[2] Fondazione IRCCS Policlinico San Matteo,Division of Infectious Diseases
[3] University of Modena,Division of Infectious Diseases
[4] ASST Papa Giovanni XXIII,Microbiology and Virology Laboratory
[5] Fondazione FROM,undefined
来源：
BMC Infectious Diseases | / 22卷
关键词：
Dual ART; Dolutegravir; Lamivudine; Switch; Simplification; Long-term follow-up; Cohort;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effectiveness, Durability, and Safety of Dolutegravir and Lamivudine Versus Dolutegravir, Lamivudine, and Abacavir in a Real-Life Cohort of HIV-Infected Adults
    Mendoza, Ines
    Lazaro, Alicia
    Torralba, Miguel
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (04) : 412 - 421
  • [22] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    Palacios, R.
    Perez-Hernandez, I. A.
    Martinez, M. A.
    Mayorga, M. L.
    Gonzalez-Domenech, C. M.
    Omar, M.
    Olalla, J.
    Romero, A.
    Romero, J. M.
    Perez-Camacho, I.
    Hernandez-Quero, J.
    Santos, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (05) : 815 - 819
  • [23] Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed
    Borghetti, Alberto
    Ciccullo, Arturo
    Lombardi, Francesca
    Giannarelli, Diana
    Passerotto, Rosa Anna
    Lamanna, Francesco
    Carcagni, Antonella
    Farinacci, Damiano
    Dusina, Alex
    Baldin, Gianmaria
    Zazzi, Maurizio
    Di Giambenedetto, Simona
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (05):
  • [24] Efficacy and Safety of a Simplified Lamivudine Plus Dolutegravir Dual Therapy in HIV-1-Infected Patients: A Multicenter Cohort Study in China
    Zhong, Mingli
    Chen, Chen
    Hu, Yue
    Zou, Meiyin
    Yan, Liting
    Huang, Jinlong
    Lv, Ru
    Su, Yifan
    Qi, Mingxue
    Ye, Zi
    Pei, Xueyu
    Ma, Ping
    Wei, Hongxia
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 91 : S42 - S50
  • [25] Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study
    Vasylyev, Marta
    Wit, Ferdinand W. N. M.
    Jordans, Carlijn C. E.
    Soetekouw, Robin
    van Lelyveld, Steven F. L.
    Kootstra, Gert-Jan
    Delsing, Corine E.
    Ammerlaan, Heidi S. M.
    van Kasteren, Marjo E. E.
    Brouwer, Annemarie E.
    Leyten, Eliane M. S.
    Claassen, Mark A. A.
    Hassing, Robert-Jan
    den Hollander, Jan G.
    van den Berge, Marcel
    Roukens, Anna H. E.
    Bierman, Wouter F. W.
    Groeneveld, Paul H. P.
    Lowe, Selwyn H.
    van Welzen, Berend J.
    Richel, Olivier
    Nellen, Jeannine F.
    van den Berk, Guido E. L.
    van der Valk, Marc
    Rijnders, Bart J. A.
    Rokx, Casper
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
  • [26] Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
    Gianotti, Nicola
    Poli, Andrea
    Nozza, Silvia
    Galli, Laura
    Galizzi, Nadia
    Ripa, Marco
    Merli, Marco
    Carbone, Alessia
    Spagnuolo, Vincenzo
    Lazzarin, Adriano
    Castagna, Antonella
    BMC INFECTIOUS DISEASES, 2017, 17
  • [27] Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy
    Barreiro, P
    de Mendoza, C
    Camino, N
    García-Benayas, T
    Blanco, F
    Núñez, M
    González-Lahoz, J
    Soriano, V
    HIV CLINICAL TRIALS, 2003, 4 (06): : 361 - 371
  • [28] Lamivudine-associated macrocytosis in HIV-infected patients
    Khawcharoenporn, Thana
    Shikuma, Cecilia M.
    Williams, Andrew E.
    Chow, Dominic C.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (01) : 39 - 40
  • [29] Dual Raltegravir-Etravirine Combination as Maintenance Regimen in Virologically Suppressed HIV-1-Infected Patients
    Calza, Leonardo
    Magistrelli, Eleonora
    Colangeli, Vincenzo
    Manfredi, Roberto
    Borderi, Marco
    Rossi, Nicolo'
    Conti, Matteo
    Mancini, Rita
    Viale, Pierluigi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (07) : 632 - 638
  • [30] DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain
    Sequera-Arquelladas, Sergio
    Hidalgo-Tenorio, Carmen
    Lopez-Cortes, Luis
    Gutierrez, Alicia
    Santos, Jesus
    Tellez, Francisco
    Omar, Mohamed
    Ferra-Murcia, Sergio
    Fernandez, Elisa
    Javier, Rosario
    Garcia-Vallecillos, Coral
    Pasquau, Juan
    VIRUSES-BASEL, 2024, 16 (02):
12345